Full video transcriptClick to expand
Auto-generated transcript of @peps.uni's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Hi, I am Salanc.
- 0:01I call anxiety to master the mind.
- 0:04I bring power and control,
- 0:05never the heavy fog that old medicines provide.
- 0:08Hi, I am anxiety.
- 0:09I make your mind loud, exhausting, and wild.
- 0:12Salanc tames my chaos in minutes,
- 0:13and now I'm just a gentle breeze.
- 0:16I am the GABAA receptor.
- 0:18Salanc turns my locks with perfect gentleness.
- 0:20True relaxation flows without compromising energy.
- 0:24Hi, I am Focus.
- 0:25Salanc gives me an unbreakable steady glow
- 0:27from a calm mind, sharp thoughts, and no distractions.
- 0:30Get ready for pure flow.
- 0:32I am BDNF, the protein chain.
- 0:34Salanc is my favorite boost.
- 0:35Together we grow new connections, stronger memories,
- 0:38and a brain that keeps getting stronger.
Selank on TikTok: separating Russian research from real evidence
Quick answer
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical settings for generalized anxiety disorder. The most cited human trial (Zozulya et al., 2008) involved 62 patients and found anxiety reduction comparable to a benzodiazepine, but this has not been independently replicated in a large RCT. Selank is not FDA-approved, and its BDNF-related effects on memory and neuroplasticity remain at the animal-model stage.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Selank on TikTok: separating Russian research from real evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Selank on TikTok: separating Russian research from real evidence is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Selank on TikTok: separating Russian research from real evidence" from aipeps.uni. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical settings for generalized anxiety disorder.
The reason this review is not generic is the source wording and the canonical claim label "peptides selank peptide biohacking nootropics." In this clip, the useful excerpt is: "Hi, I am Salanc." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical settings for generalized anxiety disorder.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Selank is a synthetic analogue of the immunomodulatory peptide tuftsin, studied primarily in Russian clinical settings for generalized anxiety disorder. The most cited human trial (Zozulya et al., 2008) involved 62 patients and found anxiety reduction comparable to a benzodiazepine, but this has not been independently replicated in a large RCT. Selank is not FDA-approved, and its BDNF-related effects on memory and neuroplasticity remain at the animal-model stage.
- Selank is not FDA-approved. It exists as a research peptide with no regulatory pathway completed in the United States or most Western countries.
- The strongest human anxiety data comes from a single 62-patient Russian trial (Zozulya et al., 2008), which has not been independently replicated in a large randomized controlled trial.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Selank is not FDA-approved. It exists as a research peptide with no regulatory pathway completed in the United States or most Western countries.
- The strongest human anxiety data comes from a single 62-patient Russian trial (Zozulya et al., 2008), which has not been independently replicated in a large randomized controlled trial.
- BDNF upregulation by Selank has been shown in rat hippocampal models (Inozemtsev et al., 2007) but has not been confirmed in human neuroimaging or memory outcome studies.
- The claim that Selank works 'in minutes' for anxiety is not supported by any published human pharmacokinetic or clinical outcome data.
- Comparing Selank favorably to licensed anxiolytics without disclosing the evidence gap is misleading and could encourage unsupervised substitution of prescribed medications.
- Compounded peptide products sold online have no standardized purity or dosing requirements, meaning what is labeled as Selank may vary significantly between suppliers.
- BDNF is also increased by aerobic exercise, sleep, and dietary factors. Attributing cognitive improvement exclusively to Selank ignores a much larger and better-evidenced literature.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @peps.uni actually say?
The video uses a theatrical format where Selank, anxiety, a GABA-A receptor, focus, and BDNF each speak in first person. The core claims are: Selank controls anxiety "in minutes," activates GABA-A receptors with "perfect gentleness," delivers relaxation without mental fog, and boosts BDNF to "grow new connections" and strengthen memory. The creator also contrasts Selank favorably against "old medicines," implying it is superior to existing anxiolytics.
The presentation is polished and confident. Phrases like "unbreakable steady glow" and "brain that keeps getting stronger" read more like marketing copy than scientific description. That does not automatically make the claims false, but it is worth slowing down and checking what the actual evidence says, because the video does not cite a single study.
Does the science back this up?
Partially, but with real caveats. Selank is a synthetic heptapeptide derived from tuftsin. Most of the evidence comes from Russian and Eastern European clinical trials, which is a problem for reproducibility and regulatory acceptance in Western medicine.
On the GABA-A claim: a 2001 study by Semenova et al. in the Bulletin of Experimental Biology and Medicine found Selank modulates GABAergic transmission in rats, supporting the receptor mechanism described. However, calling it "perfect gentleness" overstates the precision of the evidence. On BDNF: a 2007 study by Inozemtsev et al. published in Zhurnal Vysshei Nervnoi Deyatelnosti reported Selank increased BDNF expression in rat hippocampal tissue. The jump from rat hippocampus to "stronger memories" in humans is a significant leap that the video does not flag. On anxiety reduction: a 2008 Russian clinical trial by Zozulya et al. in Bulletin of Experimental Biology and Medicine found Selank comparable to fenazepam in reducing anxiety scores in 62 patients with generalized anxiety disorder. That is the strongest human data available, but the sample was small and the trial was not replicated in a large independent RCT.
What did they get wrong or right?
The GABA-A mechanism and the BDNF connection are not fabricated. Credit where it is due: the creator is pointing at real pharmacological research. The claim that Selank "tames chaos in minutes" deserves more scrutiny though. The Zozulya 2008 trial measured outcomes over days to weeks, not minutes. No peer-reviewed human study has demonstrated acute anxiety relief within a few minutes of Selank administration.
The implied comparison to "old medicines" providing "heavy fog" is the most irresponsible part. That framing nudges viewers toward self-substituting Selank for prescribed anxiolytics. Selank is not approved by the FDA. It is not a proven replacement for any licensed medication. Presenting it as clearly superior, without noting the thin human trial data, is misleading and potentially harmful.
- The GABA-A receptor interaction: mostly supported by animal studies.
- BDNF boosting: supported in rodent models, unconfirmed in robust human trials.
- "Tames anxiety in minutes": not supported by available human evidence.
- "No heavy fog unlike old medicines": a comparison made with no cited evidence.
What should you actually know?
Selank is a research peptide. It is not FDA-approved and is not legally prescribed in the United States for any condition. The existing human clinical data is limited to small trials, mostly conducted in Russia, with no large-scale independent replication. That does not make it worthless as a subject of research, but it does mean the confidence the video projects is ahead of the evidence.
BDNF is a real and important neurotrophin. But "growing new connections" is a simplification of neuroplasticity that applies to many lifestyle factors, including exercise and sleep. Attributing that effect specifically and exclusively to Selank based on rat data is a stretch.
If you are managing anxiety, changing or supplementing your treatment without medical supervision carries real risk. The fact that something avoids "heavy fog" does not make it safe or effective. Formulations sold online as Selank also vary widely in purity and concentration, since there is no regulatory standard for compounded peptide products in this category.
Bottom line
The video gets the basic pharmacology directionally right but presents a research peptide as if it were a proven, fast-acting anxiolytic. The human evidence is thin, the "minutes" claim is unsupported, and the implicit comparison to licensed medications is irresponsible without a disclaimer. Interesting peptide, overstated video.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
aipeps.uni · TikTok creator
20.0K views on this video
Selank 🧬 #peptide #biohacking #Nootropics
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about selank?
Selank is not FDA-approved. It exists as a research peptide with no regulatory pathway completed in the United States or most Western countries.
What does the video say about the strongest human anxiety data comes from a single 62-patient?
The strongest human anxiety data comes from a single 62-patient Russian trial (Zozulya et al., 2008), which has not been independently replicated in a large randomized controlled trial.
What does the video say about bdnf upregulation by selank has been shown in rat hippocampal?
BDNF upregulation by Selank has been shown in rat hippocampal models (Inozemtsev et al., 2007) but has not been confirmed in human neuroimaging or memory outcome studies.
What does the video say about the claim?
The claim that Selank works 'in minutes' for anxiety is not supported by any published human pharmacokinetic or clinical outcome data.
What does the video say about comparing selank favorably to licensed anxiolytics without disclosing the evidence?
Comparing Selank favorably to licensed anxiolytics without disclosing the evidence gap is misleading and could encourage unsupervised substitution of prescribed medications.
What does the video say about compounded peptide products sold online have no standardized purity?
Compounded peptide products sold online have no standardized purity or dosing requirements, meaning what is labeled as Selank may vary significantly between suppliers.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by aipeps.uni, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.